A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment-Reference-Cited by-同舟云学术

A case study using the PrOACT-URL and BRAT frameworks for structured benefit risk assessment

Published:2015-01-26 Issue:1 Volume:58 Page:8-27
ISSN:0323-3847
Container-title:Biometrical Journal
language:en
Short-container-title:Biom. J.

Author:

Nixon Richard¹^ORCID,Dierig Christoph²,Mt-Isa Shahrul³,Stöckert Isabelle²,Tong Thaison⁴,Kuhls Silvia²,Hodgson Gemma⁵,Pears John⁶,Waddingham Ed³,Hockley Kimberley³,Thomson Andrew⁷

Affiliation:

1. Novartis Pharma AG; Statistical Methodology and Consulting; CH-4002 Basel Switzerland

2. Bayer Pharma AG; Global Development; D-42096 Wuppertal Germany

3. School of Public Health; Imperial College London, St. Mary's Campus; Norfolk Place London W2 1PG UK

4. Health Economics and Decision Science (HEDS); School of Health and Related Research (ScHARR); University of Sheffield; Regent Court, 30 Regent Street Sheffield S1 4DA UK

5. Qi Statistics, Penhales House; Ruscombe Berkshire RG10 9JN UK

6. Astra Zeneca, R&D Global Regulatory Affairs; Mereside, Alderley Park Macclesfield Cheshire SK10 4TG UK

7. Vigilance & Risk Management of Medicines Division; Medicine and Healthcare Products Regulatory Agency; 151 Buckingham Palace Road London SW1W 9SZ

Publisher

Wiley

Subject

Statistics, Probability and Uncertainty,General Medicine,Statistics and Probability

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bimj.201300248/fullpdf

Reference32 articles.

1. Multiple Criteria Decision Analysis

2. Introduction to Meta-Analysis

3. An evaluation of the basic tasks model of graphical perception;Carswell;Human Factors,1992

4. Graphical perception-theory, experimentation, and application to the development of graphical methods;Cleveland;Journal of the American Statistical Association,1984

5. Graphical perception and graphical methods for analyzing scientific data;Cleveland;Science,1985

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A proposal for using benefit-risk methods to improve the prominence of adverse event results when reporting trials;Trials;2024-06-22

2. Application of Proact Model in Innovation Decision-Making;Challenges in the Turbulent Economic Environment and Organizations’ Sustainable Development;2024-05-20

3. Methodological guidelines and publications of benefit–risk assessment for health technology assessment: a scoping review protocol;BMJ Open;2023-12

4. Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis (MCADA) for Clinical Development;2023-09-02

5. RETRACTED: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis;Pharmaceutics;2023-05-22